Global Health Matters January/February 2024
India’s impact on global health
India has the largest population in the world and boasts one of the largest diaspora populations. And when it comes to the world of global health and medicine, the nation is a powerhouse. Between 2022 and 2023, Fogarty funded over 30 studies in the country covering such diverse topics as eye health, mental health, environmental exposures, women’s health, and more.
USAID awards $45 million to African scientists developing HIV vaccine
The BRILLIANT Consortium will implement the HIV Vaccine Innovation, Science, and Technology Acceleration in Africa program.
Seeing is believing: My year helming the Fogarty International Center
Acting Fogarty Director Peter Kilmarx recounts his experience witnessing Fogarty's impact on global health firsthand during a multi-country trip to Africa, Asia and Europe.
Finding the connection between malaria and brain development
Dr. Chandy John researches how and why severe malaria affects cognition in children. “The preliminary data are quite clear in showing that severe malaria affects cognition long-term.”
FDA approves first chikungunya vaccine
Ixchiq, the world’s first chikungunya vaccine, was approved by the U.S. Food and Drug Administration (FDA) on November 9, 2023. The FDA considers chikungunya an emerging global health threat with at least 5 million cases reported over the past 15 years.
Finding causes of heart failure in Western Kenya
Dr. Gerald Bloomfield's Fogarty project led to the development of a Cardiovascular Center of Excellence in Kenya.
Research Roundup: November 2023–January 2024
Read recently published studies from Fogarty's Division of International Epidemiology & Population Studies on topics from clean cooking interventions to flu modeling.
Also In This Issue
- People in global health news
- Global health briefs
- How to use an opinion piece to promote your research
Subscribe
Subscribe to Fogarty's Global Health Matters newsletter.
Archive
Global Health Matters is produced by the Office of Communications at the National Institutes of Health's Fogarty International Center. For more information about Global Health Matters, please refer to our Office of Communications page for contact information.
Permission to reprint Global Health Matters content: All text produced in this newsletter is in the public domain and may be reprinted. Please credit Fogarty International Center. Images must be cleared for use with the individual source, as indicated.
Updated February 13, 2024
To view Adobe PDF files, download current, free accessible plug-ins from Adobe's website .